glp 1 medications mechanism of action GLP-1 Receptor Agonists as Treatments for Type 2 Diabetes Glucagon-like peptide 1 receptor agonists:

Starting at 7.5 mg produces nausea rates above 40% in GLP-1-naive patients (Frias et al., Lancet 2021)

The issue you mention is a very real side effect - however, I address it in a completely different way by substituting the .9% Bacteriostatic Saline diluent solution with a proprietary blend of a wound wash Irrigant solution comprised of NanoMetallic Silver Oxide

The post states plainly that yerba mate does not release GLP-1 and lacks the biological mechanism to stimulate glucagon-like peptide-1 secretion in the gut or brain

Open Heart

Nacetyl cysteine and Lglutamine are important for the production and activity of glutathione